Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,563 | -20,004 | -209,409 | -146,813 | -87,987 |
| Depreciation Amortization | 1,365 | 691 | 3,235 | 2,622 | 1,710 |
| Accounts receivable | -77,385 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,074 | -50,440 | -534 | -7,990 | -2,566 |
| Other Working Capital | -68,134 | -48,071 | 10,297 | 4,845 | 2,223 |
| Other Operating Activity | 92,211 | 60,841 | 37,145 | 35,433 | 17,506 |
| Operating Cash Flow | $-44,306 | $-56,983 | $-159,266 | $-111,903 | $-69,114 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -517 | -335 | -789 | -575 | -86 |
| Purchase Of Investment | -14,864 | -14,864 | -42,869 | -42,869 | -42,869 |
| Sale Of Investment | 9,000 | N/A | 43,170 | 27,170 | 13,170 |
| Other Investing Activity | 0 | 0 | -700 | -700 | 0 |
| Investing Cash Flow | $-6,381 | $-15,199 | $-1,188 | $-16,974 | $-29,785 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 73,061 | 72,876 | N/A | N/A | N/A |
| Common Stock Issued | 9,548 | 8,601 | 103,830 | 102,064 | 101,006 |
| Other Financing Activity | 1,878 | 0 | 1,591 | 764 | 764 |
| Financing Cash Flow | $84,487 | $81,477 | $105,421 | $102,828 | $101,770 |
| Exchange Rate Effect | -229 | -136 | 468 | 330 | 213 |
| Beginning Cash Position | 73,191 | 73,191 | 127,756 | 127,756 | 127,756 |
| End Cash Position | 106,762 | 82,350 | 73,191 | 102,037 | 130,840 |
| Net Cash Flow | $33,571 | $9,159 | $-54,565 | $-25,719 | $3,084 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,306 | -56,983 | -159,266 | -111,903 | -69,114 |
| Capital Expenditure | -517 | -335 | -789 | -575 | -86 |
| Free Cash Flow | -44,823 | -57,318 | -160,055 | -112,478 | -69,200 |